This news is one step in the direction of increasing access to these effective treatments for obesity
Several studies revealed that GLP-1RAs relieve myocardial damage and glucose toxicity by promoting autophagy, which is associated with decreasing mTOR phosphorylation and increasing AMPK phosphorylation [88]
Losing weight and maintaining it can reduce the health risks associated with being overweight, including heart disease, diabetes, high blood pressure, and a shorter life expectancy
PubMed Systematic reviewGLP-1 class evidence2025 Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition Supports body-composition, lean-mass, and metabolic-risk context
Aim for at least 1.6g of protein per kilogram of body weight daily
ACT 3: The Paths That Remain So what options actually exist for patients who want access to retatrutide but can't navigate the price wall